I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ADPD 2025

-
Coming soon
08:00 AM
Duration 15mins Vienna
Evaluating future IVD plasma p-Tau181 and ApoE4 immunoassays for rule out of amyloid pathology in a multi-center study reflective of routine clinical practice
Clara Quijano-Rubio

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 15mins Vienna
Digital Health Technology feature space optimized to detect disease progression in early Parkinson’s disease under stable symptomatic treatment
Stefan Lambrecht

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:00 PM
Duration 15mins Vienna
PADOVA: Topline results from a Phase IIb study of prasinezumab in early-stage Parkinson’s disease participants on stable symptomatic treatment
Tania Nikolcheva

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:15 PM
Duration 15mins Vienna
Methodological considerations supporting a time-to-event primary endpoint in the PADOVA study in early-stage Parkinson’s disease participants on stable symptomatic treatment
Nathalie Pross

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:20 PM
Duration 15mins Vienna
Trontinemab - from early preclinical groundwork to the clinical validation of the Brainshuttle TM Platform
Luka Kulic

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:35 PM
Duration 15mins Vienna
Interim biomarker results of trontinemab, a novel Brainshuttle TM antibody in development for the treatment of Alzheimer's disease
Greg Klein

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:35 PM
Duration 15mins Vienna
Discovery of blood-based biomarkers for the detection and monitoring of amyloid related imaging abnormalities (ARIA)
Derrek Hibar

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:25 AM
Duration 15mins Vienna
Impact of ARIA on cerbral volume changes with gantenerumab
Matteo Tonietto

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:55 AM
Duration 16mins Vienna
A PHASE 1B STUDY TO TEST THE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SELNOFLAST IN EARLY-STAGE PARKINSON’S DISEASE: STUDY DESIGN AND BASELINE CHARACTERISTICS
Gennaro Pagano

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:10 PM
Duration 15mins Vienna
Two-year progression of walking and turning in daily life of early Parkinson’s disease participants: exploratory findings from the prasinezumab PASADENA study
Sara Pagnamenta

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:25 PM
Duration 15mins Vienna
Progression of remotely smartphone-collected voice impairments in early Parkinson’s disease: exploratory results from the PASADENA study of prasinezumab
Damian Kwasny

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar